Currently out of the existing stock ratings of Ying Huang, 23 are a BUY (71.88%), 5 are a HOLD (15.63%), 4 are a SELL (12.5%).

Ying Huang

Work Performance Price Targets & Ratings Chart

Analyst Ying Huang, currently employed carries an average stock price target met ratio of 80.74% that have a potential upside of 23.63% achieved within 151 days.

Ying Huang’s has documented 88 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 21-Jul-2023.

Wall Street Analyst Ying Huang

Analyst best performing recommendations are on BMRN (BIOMARIN PHARMACEUTICAL).
The best stock recommendation documented was for BMRN (BIOMARIN PHARMACEUTICAL) at 2/9/2015. The price target of $117 was fulfilled within 32 days with a profit of $23 (24.47%) receiving and performance score of 7.65.

Average potential price target upside

of $33.75 (76.76%) on BLUE (BLUEBIRD BIO).
of $30.93 (12.99%) on VRTX (VERTEX PHARMACEUTICALS).
of $24.82 (9.37%) on BIIB (BIOGEN).

ALXN Alexion Pharmaceuticals BMRN Biomarin Pharmaceutical CELG Celgene BGNE BeiGene Ltd BIIB Biogen VRTX Vertex Pharmaceuticals BLUE Bluebird bio PBYI Puma Biotechnology ICPT Intercept Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hartaj Singh (OPPENHEIMER)